The Current Ratio as of November 2024 (TTM) for YS Biopharma Co., Ltd. (YS) is 0.94

According to YS Biopharma Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 0.94. This represents a change of -31.43% compared to the average of 1.37 of the last 4 quarters.

YS Biopharma Co., Ltd. (YS) Historical Current Ratio (quarterly & annually)

How has YS Current Ratio performed in the past?

The mean historical Current Ratio of YS Biopharma Co., Ltd. over the last ten years is 1.77. The current 0.94 Current Ratio has changed 5.20% with respect to the historical average. Over the past ten years (40 quarters), YS's Current Ratio was at its highest in in the March 2022 quarter at 1.61. The Current Ratio was at its lowest in in the June 2022 quarter at 0.

YS Biopharma Co., Ltd. (YS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of YS Biopharma Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

YS Biopharma Co., Ltd. (YS) Average Current Ratio

How has YS Current Ratio performed in the past?

The current Current Ratio of YS Biopharma Co., Ltd. (YS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

YS Biopharma Co., Ltd. (YS) Current Ratio vs. Peers

How is YS’s Current Ratio compared to its peers?

YS Biopharma Co., Ltd.’s Current Ratio is less than Revelation Biosciences, Inc. (1.64), less than Cardio Diagnostics Holdings, Inc. (8.51), less than Biodexa Pharmaceuticals Plc (2.16), greater than ZyVersa Therapeutics, Inc. (0.03), less than Sonnet BioTherapeutics Holdings, Inc. (1.65), less than Allarity Therapeutics, Inc. (2.75), greater than Kiromic BioPharma, Inc. (0.22), less than Immix Biopharma, Inc. (3.47), less than CNS Pharmaceuticals, Inc. (1.82), less than eFFECTOR Therapeutics, Inc. (1.03), greater than Navidea Biopharmaceuticals, Inc. (0.56), less than Virios Therapeutics, Inc. (7.27), less than Zura Bio Limited (10.36), less than Quoin Pharmaceuticals, Ltd. (3.02), less than Virax Biolabs Group Limited (25.94),

Build a custom stock screener for YS Biopharma Co., Ltd. (YS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like YS Biopharma Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

YS Biopharma Co., Ltd. (YS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like YS Biopharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.